Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.
about
Topoisomerase I in Human Disease Pathogenesis and TreatmentsComprehensive Assessments of RNA-seq by the SEQC Consortium: FDA-Led Efforts Advance Precision MedicineA survey of current trends in computational drug repositioningStatin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesionSurvival of patients with stage IV lung cancer with diabetes treated with metformin.ksRepo: a generalized platform for computational drug repositioningIntrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy.Clinical Outcomes of Patients with Rare and Heavily Pretreated Solid Tumors Treated according to the Results of Tumor Molecular Profiling.Gasotransmitters in cancer: from pathophysiology to experimental therapy.Personalized medicine in hematology - A landmark from bench to bedIndividualized network-based drug repositioning infrastructure for precision oncology in the panomics era.Etirinotecan pegol for the treatment of breast cancer.The Clinical Effect of Metformin on the Survival of Lung Cancer Patients with Diabetes: A Comprehensive Systematic Review and Meta-analysis of Retrospective Studies.Drug-diagnostics co-development in oncology.Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.
P2860
Q26749484-1B61017D-BA80-41C6-AE14-46EF4FE6EE6DQ26752996-4298068A-71D8-4089-8DCB-3ECC7A17AE2BQ28602324-1641220E-FAC5-4082-B176-313E414E85D4Q34760888-5C0E7639-C749-4992-B9D7-3098F3E22F62Q35153493-045EC921-B90F-4F54-98E1-B1A937F66230Q35918546-2C87E49F-39BC-4629-AEB4-5EAE86E6C7DBQ36278688-B1BD04E4-7AE0-4922-A020-A394DF3695A3Q37150582-BE1F5BB9-4D3F-443B-98BB-109B90703D5FQ37656625-193716F5-C6AC-4A87-8428-2CA4B2AC3F06Q38263199-2FFCE71F-7730-4212-AB3D-43D45F970EE8Q38379632-1F6C60EF-D1BA-412C-9398-13B75432D121Q38735361-FDFF5E26-6314-4DC2-B51B-E53D4EAA36A9Q41242882-21780037-5C31-4896-B008-5C3513037B36Q41883789-99125099-D10B-4F66-AA23-99ADA4C4F663Q51210845-518CDBBF-59D1-4E85-BB95-06E676BFD4C7
P2860
Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarker-guided repurposing o ...... strategy in drug development.
@en
Biomarker-guided repurposing o ...... strategy in drug development.
@nl
type
label
Biomarker-guided repurposing o ...... strategy in drug development.
@en
Biomarker-guided repurposing o ...... strategy in drug development.
@nl
prefLabel
Biomarker-guided repurposing o ...... strategy in drug development.
@en
Biomarker-guided repurposing o ...... strategy in drug development.
@nl
P2093
P2860
P356
P1476
Biomarker-guided repurposing o ...... l strategy in drug development
@en
P2093
David Hersi Smith
Dorte Nielsen
Iben Kümler
Nils Brünner
Sune Boris Nygård
P2860
P356
10.3389/FONC.2013.00313
P577
2013-12-25T00:00:00Z